Catch up on Penington Institute's webinar, Hydromorphone for Opioid Use Disorder': Insights from the Feasibility of Opioid Injecting Trial', recorded live on 03 Apr 2024.
WEBINAR DETAILS:
This webinar examines the use of hydromorphone for opioid use disorder and gives insights from the feasibility of opioid injecting trial.
Supervised Injectable Opioid Treatment is a proven intervention designed for individuals with opioid dependence when conventional treatments have not been effective. Research highlights its success in reducing illicit opioid use, curbing crime rates, and enhancing overall health and wellbeing.
Despite its benefits, injectable hydromorphone treatment remains a topic of controversy.
Uniting NSW. ACT, UNSW, and St Vincent’s Hospital Sydney, partnered on this initiative to evaluate the acceptability of injectable hydromorphone within an Australian context.
Do the results pave the way for a significant shift? Our expert panel will discuss various aspects of the trial, including its unique features, feasibility challenges, and potential pathways for future expansion.
This webinar is hosted by an expert panel:
-Dr Craig Rodgers, Senior Staff Specialist, Alcohol and Drug Service, St Vincents Hospital (Sydney)
-Maureen Steel, Consumer participation worker, St Vincents Hospital (Sydney)
-Anna McVinish, Clinical Nurse Consultant, St Vincents Hospital (Sydney)
-Dr Jake Rance, Research Fellow, University of New South Wales
The panel discussion will be facilitated by our Senior Research Officer, Dr Jake Dizard.
Don’t miss this opportunity to discover more about this unique trial.